Medicine by Design 9th Annual Symposium : Driving translation with transformative science

Event details at a glance

Date: Monday, December 9, 2024
Time: 8:15 a.m. to 6:00 p.m.
Venue: MaRS Auditorium, 101 College Street

About the symposium

This year’s symposium is themed “Driving translation with transformative science.” Invited speakers and Medicine by Design principal investigators will focus on telling strong translational stories, starting with leading edge science and enabling technologies through to commercialization and patient impact.

Since 2016, Medicine by Design has married high risk, high reward research, with a strategy for accelerating the translation of emerging innovations toward new regenerative medicine products and companies.

Plenary speakers and panelists

Anna Falk, PhD
Anna Falk, PhDChief Scientific Officer, CCRM Nordic and Professor, Department of Experimental Medical Science, Lund University
https://portal.research.lu.se/en/persons/anna-falk
Bettina Hamelin, PhD
Bettina Hamelin, PhDPresident, Innovative Medicines Canada
https://www.linkedin.com/in/bettina-hamelin-1060834/?originalSubdomain=ca
David Malkin, MD
David Malkin, MDLead, Precision Child Health Initiative and Senior Staff Oncologist, The Hospital for Sick Children, and Professor, Departments of Pediatrics and Medical Biophysics, University of Toronto
https://www.sickkids.ca/en/staff/m/david-malkin/
Laura Niklason, PhD, MD
Laura Niklason, PhD, MDFounder, President, and Chief Executive Officer, Humacyte Global Inc. and Professor, Departments of Anesthesia and Biomedical Engineering, Yale University
https://medicine.yale.edu/profile/laura-niklason
Philip Tagari, PhD
Philip Tagari, PhDChief Scientific Officer, insitro
https://www.insitro.com/leadership/philip-tagari
Fyodor Urnov, PhD
Fyodor Urnov, PhDDirector, Technology and Translation, Innovative Genomics Institute and Professor, Department of Molecular Therapeutics, University of California, Berkeley
https://innovativegenomics.org/people/fyodor-urnov

Medicine by Design speakers

Gary Bader, PhD
Gary Bader, PhDProfessor, Department of Molecular Genetics, University of Toronto
https://baderlab.org/
Kullervo Hynynen, PhD
Kullervo Hynynen, PhDVice President, Research and Innovation and Senior Scientist, Sunnybrook Health Sciences Centre and Professor, Department of Medical Biophysics, University of Toronto
https://sunnybrook.ca/research/team/member.asp?m=86&page=184
Elmar Jaeckel, MD
Elmar Jaeckel, MD Medical Director, Toronto Liver Transplant Program, University Health Network, and Professor, Department of Medicine, University of Toronto
https://bbdc.org/members-research/jaeckel-elmar/
Sonya MacParland, PhD
Sonya MacParland, PhDSenior Scientist, Toronto General Hospital Research Institute, University Health Network, and Associate Professor, Department of Laboratory Medicine and Pathobiology, University of Toronto
https://www.uhnresearch.ca/researcher/sonya-macparland
Cristina Nostro, PhD
Cristina Nostro, PhDSenior Scientist, McEwen Stem Cell Institute, University Health Network, and Associate Professor, Department of Physiology, University of Toronto
https://www.uhnresearch.ca/researcher/maria-cristina-nostro
Milica Radisic, PhD
Milica Radisic, PhDProfessor, Institute of Biomedical Engineering, Department of Chemical Engineering and Applied Chemistry and Senior Scientist, Toronto General Hospital Research Institute, University Health Network
https://radisiclab.com/
Trevor Reichman, MD
Trevor Reichman, MDSurgical Director, Pancreatic Transplant Program, University Health Network and Associate Professor, Department of Surgery, University of Toronto
https://www.uhn.ca/PatientsFamilies/Search_Doctors/Pages/doctor_detail.aspx?doctor=985
Thomas Waddell, PhD, MD
Thomas Waddell, PhD, MDThoracic Surgeon and Senior Scientist, Toronto General Hospital Research Institute, University Health Network, and Professor, Department of Surgery, University of Toronto
https://www.uhnresearch.ca/researcher/thomas-k-waddell

Poster session

Research labs across the University of Toronto and its affiliated hospitals will have the opportunity to showcase their innovative regenerative medicine research.

Deadline extended to October 18, 11:59 P.M.

Regenerative Medicine  

Medicine by Design has a broad perspective on the definition of regenerative medicine. The field includes the use of derivatives of stem cells and/or gene therapy to replace diseased tissues and organs, creating therapies in which cells are the biological product. Regenerative medicine can also mean triggering stem cells that are already present in the human body to repair damaged tissues or to modulate immune responses. This approach is often referred to as endogenous repair and can include novel small molecules and/or biologic candidates, as well as biomaterials. Increasingly, regenerative medicine researchers are using a stem cell lens to identify critical interactions or defects that prepare the ground for disease, paving the way for new approaches to preventing disease before it starts. Enabling technologies such as cell manufacturing platforms and stem cell-based organ-on-chip technologies are also important aspects of the field and areas of interest to Medicine by Design. 

Sponsors

Contact

Please email info.mbd@utoronto.ca if you have any questions about the symposium.